Singapore child NCIS dose schedule, dates and the MediSave COVID-19 vaccine claim

From 12 October 2026, COVID-19 vaccination is included in Singapore's National Childhood Immunisation Schedule (NCIS) — but inclusion is not a recommendation for every child under 12. The recommended group covers medically vulnerable children aged six months and above. Other children aged six months and above may still choose to receive it. Doses and products then depend on your child's age band and the date. ^{[1] [2]}

This is a dated checklist built from the Ministry of Health and Communicable Diseases Agency release of 7 October 2026: who is inside the recommended groups, how many doses a first-time child receives, which vaccine a child under 12 can be given on which date, and the subsidy and MediSave terms as written. CDA's vaccinations page, last updated 22 May 2026, listed 14 diseases under the NCIS and made measles and diphtheria vaccinations compulsory under the Infectious Diseases Act. Nothing here assesses your child's eligibility. ^{[3] [1]}

Is your child inside the recommended group?

MOH and CDA list three recommended groups for COVID-19 vaccination under the NCIS and National Adult Immunisation Schedule: individuals aged 60 years and above; medically vulnerable individuals aged six months and above; and residents of aged care facilities. For children, CNA reported that this means vaccination will be recommended under the NCIS for those with certain medical conditions that put them at greater risk. So the first question is not the date, but whether a doctor has identified your child as medically vulnerable. ^{[1] [4]}

CNA's report of the same announcement lists examples of conditions counted as medically vulnerable: diabetes; heart conditions such as heart failure; chronic lung, kidney and liver conditions; and pregnancy. These are examples, not the complete list, which MOH publishes on its website. Healthcare workers, and people who live or work with medically vulnerable individuals, are encouraged to get vaccinated. Everyone else aged six months and above may continue to receive the vaccine, and may consult their doctor about the benefits for their specific situation. ^{[4] [2]}

How many doses, and how far apart?

The dose wording is short and exact. Unvaccinated children receiving COVID-19 vaccination for the first time should receive two vaccine doses, eight weeks apart, if they are six months to four years, and one vaccine dose if they are five years and older. A child's age on the day of the first dose therefore decides whether the plan involves two appointments or one. ^[1]

Three hypothetical households read the same announcement differently. Household A has a four-year-old whom a doctor has identified as medically vulnerable: inside the recommended group, two doses eight weeks apart. Household B has a seven-year-old with no qualifying condition: outside the recommended group, one dose if the family chooses it after a doctor conversation. Household C has an eleven-year-old: also outside the recommended group, also one dose, but on a different product timeline. These examples illustrate the wording only. ^{[1] [2] [4]}

Which vaccine is available, and on which date?

The updated products are the XFG Moderna/Spikevax and XFG Pfizer-BioNTech/Comirnaty formulations, approved by the Health Sciences Authority. MOH and CDA state that they provide better protection against current and emerging strains of COVID-19, and that their safety profiles are comparable to those of previous versions. That is the authorities' own statement about these products, not an independent comparison. ^[1]

For a child under 12, the dates decide which products are on offer. From 12 October 2026, the updated Pfizer-BioNTech/Comirnaty vaccine is administered for individuals aged 12 years and above, and Moderna/Spikevax for individuals aged six months and above. From 2 November 2026, the updated Pfizer-BioNTech/Comirnaty vaccine is administered for individuals aged six months to 11 years. Both updated vaccines roll out at more than 600 GP clinics, all polyclinics and Mobile Vaccination Team sites. So Household C's eleven-year-old can receive the updated Moderna/Spikevax from 12 October 2026; only the updated Pfizer-BioNTech/Comirnaty option for that age band waits until 2 November 2026. ^{[1] [2]}

Booking and paying

Appointments at participating GP clinics can be booked at vaccine.gov.sg/covid, and the release advises contacting the clinic to confirm vaccine availability before visiting. Polyclinic appointments are booked through HealthHub, and Healthier SG enrollees are encouraged to visit their enrolled clinic for vaccination if the clinic offers COVID-19 vaccination. Availability, rather than eligibility, is the step most likely to change a plan. ^[1]

On cost, the release says COVID-19 vaccination continues to be fully subsidised for Singapore Citizens, Permanent Residents, Long Term Pass Holders and certain Short Term Pass Holders at participating CHAS GP clinics, polyclinics and MVT sites, until further review. It adds that COVID-19 vaccinations will not be claimable under MediSave 500/700, or the MediSave Chronic and Preventive Care scheme from 1 January 2027, until further review. The release states no price for a family outside those categories. ^{[2] [1]}

Planning your next step

If your child has already had a COVID-19 dose, the interval to plan around is different: for those aged six months and above who have previously been vaccinated, an additional dose should be received around one year, and at least five months, after the last dose. A suggestion for your own notes, not an official step: write down your child's age, note whether a doctor has identified a qualifying condition, and ask the clinic which product it holds for that age on the date you can attend. ^[1]

Back to the question: the 12 October 2026 schedule entry does not mean every family with a child under 12 should book a dose. It means COVID-19 vaccination is now part of Singapore's routine national schedules, with the recommendation under the NCIS applying to medically vulnerable children aged six months and above, while other children aged six months and above may still choose it after a doctor conversation. Doses differ by age band, and for a child under 12 the updated Pfizer-BioNTech/Comirnaty option begins on 2 November 2026. For the listed pass-holder categories the dose is fully subsidised at participating sites and is not a MediSave claim. ^{[1] [2]}

Sources

EduNanny Editorial · AI-assisted research and writing, reviewed by our automated editorial team. Sources checked 2026-10-09. Featured image: AI-generated editorial illustration.